Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Scientific Reports|July 10, 2024
Characterizing soluble immune checkpoint molecules and TGF-β1,2,3 in pleural effusion of malignant pleural mesotheliomaRiki Okita, Tomoya Senoo, Yuka Mimura-Kimura, et al.
General Thoracic and Cardiovascular Surgery|March 19, 2022
Safety of salvage lung resection after immunotherapy for unresectable non-small cell lung cancerTsuyoshi Ueno, Motohiro Yamashita, Natsumi Yamashita, et al.
Chest|June 23, 2018
Tumor Spread Through Air Spaces Identifies a Distinct Subgroup With Poor Prognosis in Surgically Resected Lung Pleomorphic CarcinomaShintaro Yokoyama, Tomoyuki Murakami, Hiroyuki Tao, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2022
Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomyRiki Okita, Yuka Mimura-Kimura, Nobutaka Kawamoto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Trends in lung pH and PO2 after circulatory arrest: implications for non-heart-beating donors and cell culture models of lung ischemia-reperfusion injuryGiovanna Koukoulis, Ray Caldwell, Hidetoshi Inokawa, et al.
The Annals of Thoracic Surgery|March 28, 2006
Ex vivo evaluation of human lungs for transplant suitabilityThomas M Egan, John A Haithcock, William A Nicotra, et al.
Surgery Today|June 30, 2009
Experimental orthotopic lung transplantation model in rats with cold storageRyujiro Sugimoto, Atsunori Nakao, Itaru Nagahiro, et al.
Bioscience of Microbiota, Food and Health|May 21, 2016
Perioperative supplementation with bifidobacteria improves postoperative nutritional recovery, inflammatory response, and fecal microbiota in patients undergoing colorectal surgery: a prospective, randomized clinical trialMinoru Mizuta, Izuru Endo, Sumiharu Yamamoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2021
Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With EGFR Mutation (IMPACT)Hirohito Tada, Tetsuya Mitsudomi, Toshihiro Misumi, et al.
Annals of Surgical Oncology|June 24, 2023
EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After SurgeryToshiya Fujiwara, Kazuhiko Shien, Motoki Matsuura, et al.
Pageof 5